Navegar por autor "Molina Perez, Esther"

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Lariño Noia, José; Álvarez del Castillo, Matilde; [et al.]

Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático

2012- Alvarez Castro, Ana Maria; Seijo Rios, Susana; Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo [et al.]

Calcineurin inhibitors in liver transplantation: to be or not to be.

2011- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo

Characterization of HBsAg loss in patients with chronic hepatitis b (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS)

2015- Molina Perez, Esther

Characterization of HBsAg loss in patients with chronic hepatitis B (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS)

2015- Molina Perez, Esther

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)

2013- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau; Baleato Gonzalez, Sandra; [et al.]

Colangitis esclerosante

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique

Comienzo de hepatitis aguda grave autoinmune refractaria a tratamiento convencional, rescatada con infliximab

2014- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau

Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol

2014- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Souto Rodríguez, Raquel; Fernández Pérez, Aquilino; [et al.]

Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

2015- Molina Perez, Esther

Effectiveness of triple therapy in clinical practice for treatment-naive HCV patients with advanced hepatic fibrosis. Virologic response data at 12 weeks post-treatment (SVR-12W)

2014- Molina Perez, Esther

III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, living-donor liver transplantation, quality of liver grafts and of liver transplantation programs

2011- Molina Perez, Esther; Delgado Blanco, Manuel

Indicaciones actuales de tratamiento triple para la hepatitis C

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique

Influence of dietary habits in susceptibility for inflammatory bowel disease: A case control study

2011- Alvarez Castro, Ana Maria; Molina Perez, Esther; Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; [et al.]

Intestinal absorption and pancreatic function are preserved in anorexia nervosa patients in both a severely malnourished state and after recovery

2013- Molina Perez, Esther; Domínguez Muñoz, Juan Enrique; Casanueva Freijo, Felipe; Nieto Garcia, Laura; Peinó García, Roberto; [et al.]

Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed?

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo; Abdulkader Nallib, Ihab; Ferreiro Iglesias, Rocio; [et al.]

Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations

2013- Molina Perez, Esther

Pre-Immunosuppressant Hepatitis B Virus Screening Practices Among Various Medical Specialities (HEBRA Project): Results of a Survey from 19 Spanish Hospitals

2012- Molina Perez, Esther

Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study

2015- Fernandez Castroagudin, Javier; Molina Perez, Esther

Proteinuria predicts unfavourable evolution after switching of immunosupression from calcineurin-inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

2011- Molina Perez, Esther; Fernandez Castroagudin, Javier; Varo Perez, Evaristo

Repositorio digital RUNA

Navegar por autor "Molina Perez, Esther"

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy ﻿

Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático ﻿

Calcineurin inhibitors in liver transplantation: to be or not to be. ﻿

Characterization of HBsAg loss in patients with chronic hepatitis b (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS) ﻿

Characterization of HBsAg loss in patients with chronic hepatitis B (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS) ﻿

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC) ﻿

Colangitis esclerosante ﻿

Comienzo de hepatitis aguda grave autoinmune refractaria a tratamiento convencional, rescatada con infliximab ﻿

Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol ﻿

Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis ﻿

Effectiveness of triple therapy in clinical practice for treatment-naive HCV patients with advanced hepatic fibrosis. Virologic response data at 12 weeks post-treatment (SVR-12W) ﻿

III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, living-donor liver transplantation, quality of liver grafts and of liver transplantation programs ﻿

Indicaciones actuales de tratamiento triple para la hepatitis C ﻿

Influence of dietary habits in susceptibility for inflammatory bowel disease: A case control study ﻿

Intestinal absorption and pancreatic function are preserved in anorexia nervosa patients in both a severely malnourished state and after recovery ﻿

Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed? ﻿

Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations ﻿

Pre-Immunosuppressant Hepatitis B Virus Screening Practices Among Various Medical Specialities (HEBRA Project): Results of a Survey from 19 Spanish Hospitals ﻿

Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study ﻿

Proteinuria predicts unfavourable evolution after switching of immunosupression from calcineurin-inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction ﻿

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy

Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático

Calcineurin inhibitors in liver transplantation: to be or not to be.

Characterization of HBsAg loss in patients with chronic hepatitis b (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS)

Characterization of HBsAg loss in patients with chronic hepatitis B (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS)

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)

Colangitis esclerosante

Comienzo de hepatitis aguda grave autoinmune refractaria a tratamiento convencional, rescatada con infliximab

Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol

Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

Effectiveness of triple therapy in clinical practice for treatment-naive HCV patients with advanced hepatic fibrosis. Virologic response data at 12 weeks post-treatment (SVR-12W)

III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, living-donor liver transplantation, quality of liver grafts and of liver transplantation programs

Indicaciones actuales de tratamiento triple para la hepatitis C

Influence of dietary habits in susceptibility for inflammatory bowel disease: A case control study

Intestinal absorption and pancreatic function are preserved in anorexia nervosa patients in both a severely malnourished state and after recovery

Late recurrence of hepatocellular carcinoma after liver transplantation: Is an active surveillance for recurrence needed?

Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations

Pre-Immunosuppressant Hepatitis B Virus Screening Practices Among Various Medical Specialities (HEBRA Project): Results of a Survey from 19 Spanish Hospitals

Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study

Proteinuria predicts unfavourable evolution after switching of immunosupression from calcineurin-inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction